Winmark Corp Form 4 Filings

WINMARK CORP director Lawrence A. Barbetta reported a new compensation award of stock options. On 2026-06-01, he received a grant of 356 Non-Employee Director Stock Options to buy Winmark common stock at an exercise price of $378.57 per share, vesting 25% per year for four years and expiring on 2036-06-01. After this filing, he directly holds 649 shares of common stock and multiple option awards with various exercise prices and expiration dates.

WINMARK CORP director Amy C. Becker reported a new stock option grant and updated her existing option holdings. On 2026-06-01, she received a non-employee stock option covering 356 shares of common stock at an exercise price of $378.57 per share. The option becomes exercisable starting 2027-06-01 and expires on 2036-06-01, and a footnote states it vests 25% per year for four years.

The filing also lists previously granted non-employee stock options she continues to hold, including grants exercisable at $248.64 for 5,500 underlying shares expiring on 2032-11-15, and at $238.60 for 620 underlying shares expiring on 2032-12-12. The transactions disclosed are compensation-related option awards and holdings, with no open‑market purchases or sales of common stock reported.

Winmark Corp director Philip Irving Smith reported a new stock option grant and his existing option holdings. On the reported date, he received a non-employee stock option covering 356 shares of common stock at an exercise price of $378.57 per share, exercisable from June 1, 2027 until June 1, 2036. A footnote states these options vest 25% per year for four years, indicating a long-term incentive structure. The filing also lists several other non-employee stock options he holds directly, with exercise prices between $291.01 and $446.68 and individual grants ranging from 240 to 4,500 underlying shares, showing a meaningful ongoing equity-based compensation position.

Winmark Corp director Gina DeCaro Sprenger reported a new equity award. She received 356 Non-Employee Stock Options to buy Winmark common stock at an exercise price of $378.57 per share, vesting 25% per year for four years and expiring on June 1, 2036.

Following this filing, she directly holds 250 shares of common stock and multiple outstanding option grants, including one covering 10,000 underlying shares at an exercise price of $182.21 per share expiring on January 13, 2031. The transactions disclosed are compensation-related awards and holdings rather than open-market purchases or sales.

WINMARK CORP director Percy C. Tomlinson Jr. received a grant of 356 Non-Employee Stock Options to buy common stock at an exercise price of $378.57 per share. According to the footnote, the options vest 25% per year for four years starting on June 1, 2027.

After this grant, he holds 800 common shares directly and multiple outstanding option awards, including an option covering 5,400 underlying shares at a $242.58 exercise price expiring on December 14, 2031.

WINMARK CORP director Stephanie S. Hoppe reported a new stock option grant. She received 356 Non-Employee Stock Options to buy Common Stock at an exercise price of $378.57 per share, expiring on June 1, 2036, described as a grant, award, or other acquisition.

The options vest 25% per year for four years according to the footnote, indicating a multi‑year compensation structure rather than an open-market purchase. The filing also shows an existing Non-Employee Stock Option covering 3,400 underlying Common Stock shares at a $372.02 exercise price, expiring on May 5, 2036, which remains outstanding.

WINMARK CORP director Keith Credendino received a new stock option grant for 356 shares of common stock at an exercise price of $378.57 per share. The options are scheduled to vest at 25% per year over four years, aligning compensation with longer-term company performance.

After this grant, Credendino holds additional non-employee stock options that are exercisable into 256 shares at an exercise price of $444.54 and 3,000 shares at $393.64, both expiring in 2035. The new 2036-dated grant increases his overall equity-based incentive position without involving any open-market share purchases or sales in this filing.

WINMARK CORP’s chief financial officer Anthony D. Ishaug reported a new equity compensation award. On June 1, 2026 he received 2,420 Employee Stock Options, each giving the right to buy one share of common stock at an exercise price of $378.57.

These options vest at 25% per year for four years and are scheduled to expire on June 1, 2036, tying a portion of his pay to the company’s long‑term share performance. After the reported update, he directly holds 69,776 shares of common stock plus multiple earlier option grants with various exercise prices and expirations.

WINMARK CORP Chief Operating Officer Renae M. Gaudette reported an equity compensation update. The Form 4 shows a grant of 1,984 Employee Stock Options (right to buy Common Stock) at an exercise price of $378.57 per share, exercisable until an expiration date in 2036.

Following this grant, Gaudette directly holds 21,360 shares of Common Stock and a series of existing employee stock option awards with exercise prices ranging from about $122.50 to $444.54 and expirations extending through 2036. Most other line items reflect previously granted option holdings rather than new purchases or sales.

WINMARK CORP chair and CEO Brett D. Heffes reported a new grant of 4,620 employee stock options for common stock on June 1, 2026. The options have an exercise price of $378.57 per share, vest 25% per year for four years, and expire on June 1, 2036.

After this grant, Heffes holds 114,400 shares of common stock directly and 338 shares indirectly through a family office. He also retains multiple outstanding option awards with exercise prices between $176.20 and $444.54 per share and expiration dates from 2029 through 2036.

WINMARK CORP’s chief marketing officer, Lisa Schurke Hake, reported new stock option awards. On June 1, 2026, she received employee stock options covering 1,712 shares of common stock at an exercise price of $378.57 per share, and a separate grant covering 9,256 shares at the same exercise price. Both grants are scheduled to vest 25% per year for four years. The filing also shows an existing employee stock option relating to 1,216 underlying shares at an exercise price of $444.54 per share, exercisable beginning on December 15, 2026 and expiring on December 15, 2035. These awards are compensation-related grants rather than open‑market stock purchases or sales.

WINMARK CORP director Stephanie S. Hoppe received a grant of non-employee stock options covering 3,400 shares of common stock at an exercise price of $372.02 per share. The options vest 25% per year over four years and expire in 2036.

WINMARK CORP chief financial officer Anthony D. Ishaug exercised employee stock options to acquire 3,293 shares of common stock at $98.25 per share. After this derivative exercise, his direct common stock holdings reported in the filing are 69,776 shares.

The filing also lists a broad set of remaining employee stock option awards on Winmark common stock, with exercise prices ranging from $125.50 to $444.54 and expiration dates between 2026 and 2035. These option positions reflect ongoing equity-based compensation rather than open-market share purchases or sales.

WINMARK CORP Chief Operating Officer Renae M. Gaudette exercised employee stock options to acquire 2,500 shares of common stock at $98.25 per share. Following this derivative exercise, she directly holds 21,360 common shares. The filing also lists multiple remaining option grants with various exercise prices and expiration dates that vest 25% per year for four years.

Winmark Corp director Jenele C Grassle reported an open-market sale of common stock. On 2026-03-04, she sold 3,900 shares of Winmark common stock at a price of $475.8000 per share, leaving her with direct ownership of 2,500 common shares.

The filing also lists multiple holdings of Non-Employee Stock Options (right to buy), all held directly, with various share amounts remaining as of 2026-03-04. A footnote states that these options vest at a rate of 25% per year for four years.

Winmark Corp director Percy C. Tomlinson Jr. reported an open-market sale of 1,660 shares of common stock at $460.52 per share. After this transaction, he directly holds 800 Winmark common shares.

In addition to common stock, he continues to hold several non-employee stock options, including one grant covering 5,400 shares, with a noted vesting schedule of 25% per year for four years.

Winmark Corp director Percy C. Tomlinson Jr. reported exercising non-employee stock options to acquire additional common shares. On February 26, 2026, he exercised options for 1,600 shares at $242.58 per share and 60 shares at $197.80 per share.

These option exercises resulted in corresponding acquisitions of Winmark common stock, leaving him with 2,460 common shares held directly after the transactions.

Winmark Corp director Jenele C. Grassle reported exercising several non-employee stock options into common stock on February 25, 2026. She acquired a total of 3,900 shares of common stock through option exercises at strike prices ranging from $134.25 to $176.20 per share, bringing her direct common stock holdings to 6,400 shares.

Winmark Corp director Jenele C. Grassle reported insider activity involving the company’s common stock. On 12/15/2025, the director disposed of 2,500 shares of common stock. The filing also shows a new grant of 256 non-employee stock options (right to buy) with an exercise price of $444.54 per share, exercisable on 12/15/2026 and expiring on 12/15/2035, held directly. An explanatory note adds: “25% per year for four years.” The report lists additional previously granted non-employee stock options with various exercise prices and expiration dates that remain beneficially owned directly.

Winmark Corp director Gina De Caro Sprenger reported insider equity transactions. On December 15, 2025 she received 256 non-employee stock options to buy Winmark common stock at $444.54 per share. These options cover 256 shares of common stock, vest 25% per year for four years beginning December 15, 2026, and expire on December 15, 2035. The filing also shows a disposition of 250 shares of common stock and lists previously granted director stock options covering additional shares at exercise prices between $182.21 and $446.68 per share, all held directly.

Winmark Corp director Philip I. Smith reported receiving 256 non-employee stock options to purchase Winmark common stock at an exercise price of $444.54 per share on 12/15/2025. These options cover 256 shares, become exercisable beginning 12/15/2026, and expire on 12/15/2035, with vesting described as 25% per year for four years.

The report also lists previously granted non-employee stock options that remain directly owned, including a grant exercisable from 03/01/2024 until 03/01/2033 for 4,500 shares at an exercise price of $291.01 per share. All reported derivative holdings are shown as directly owned by the director.

Winmark Corp director Percy C. Tomlinson, Jr. reported insider transactions in company stock. On 12/15/2025, he disposed of 800 shares of common stock.

On the same date, he received a non-employee stock option covering 256 shares of common stock at an exercise price of $444.54 per share, exercisable beginning 12/15/2026 and expiring 12/15/2035. The option vests 25% per year for four years, and he also holds several earlier non-employee stock option grants with various exercise prices and expiration dates.

Winmark Corp director Amy C. Becker reported a new equity grant in the form of stock options. On 12/15/2025, she received a non-employee stock option for 256 shares of Winmark common stock with an exercise price of $444.54 per share. These options become exercisable starting on 12/15/2026 and have an expiration date of 12/15/2035.

A footnote explains that the option vests at a rate of 25% per year for four years, giving Becker a multi-year vesting schedule. The filing also lists several previously granted non-employee stock options with different exercise prices and expiration dates, all held in a direct ownership capacity.

Winmark Corp director Lawrance A. Barbetta reported insider transactions involving the company’s common stock. On 12/15/2025, he disposed of 649 shares of Winmark common stock and, on the same date, received a new non-employee director stock option to purchase 256 shares at an exercise price of $444.54 per share, exercisable starting 12/15/2026 and expiring 12/15/2035.

After this grant, Barbetta continues to hold multiple other director stock option awards on Winmark common stock, including options with an exercise price of $134.25 per share expiring 12/11/2027 and options with an exercise price of $261.32 per share expiring 12/13/2031. The newly reported options vest at a rate of 25% per year over four years, tying part of his compensation to Winmark’s long-term performance.

Winmark Corp reported an equity award to one of its directors. On 12/15/2025, the director received a non-employee stock option to buy 256 shares of common stock at an exercise price of $444.54 per share. The option is scheduled to vest 25% per year for four years and will be exercisable beginning 12/15/2026, with an expiration date of 12/15/2035. The filing also shows the director beneficially owns a separate non-employee stock option covering 3,000 shares at a $393.64 exercise price, exercisable from 08/07/2026 until 08/07/2035.

Winmark Corp reported an equity award to its chief marketing officer, Lisa S. Hake. On December 15, 2025, she acquired an employee stock option covering 1,216 shares of common stock at an exercise price of $444.54 per share. The option becomes exercisable starting December 15, 2026 and expires on December 15, 2035.

According to the vesting terms, the award vests in four equal installments of 25% per year over four years. After this grant, Hake beneficially owns 1,216 stock options, held directly. This type of award is a form of equity-based compensation that links a senior executive’s potential future gains to the company’s share price.

Winmark Corp's chief operating officer Renae M. Gaudette reported receiving an employee stock option grant on 12/15/2025. The grant covers 1,316 options to buy Winmark common stock at an exercise price of $444.54 per share and is first exercisable on 12/15/2026.

These options expire on 12/15/2035 and vest at a rate of 25% per year for four years. Following the reported transactions, Gaudette directly owns 18,860 shares of Winmark common stock and continues to hold multiple prior option grants with various exercise prices and expirations.

Winmark Corp’s chief financial officer reported a new stock option grant and updated equity holdings. On 12/15/2025, the officer received an employee stock option to buy 1,712 shares of common stock at an exercise price of $444.54 per share. This option becomes exercisable on 12/15/2026, expires on 12/15/2035, and is subject to a vesting schedule of 25% per year for four years. Following the reported transactions, the officer directly beneficially owned 66,483 shares of Winmark common stock and held multiple additional employee stock option awards with various exercise prices and expiration dates.

Winmark Corp chair and CEO Brett D. Heffes filed an insider ownership report reflecting equity activity on 12/15/2025. The filing shows a grant of employee stock options to purchase 2,712 shares of Winmark common stock at an exercise price of $444.54, exercisable from 12/15/2026 to 12/15/2035 and vesting 25% per year over four years.

After the reported transactions, Heffes beneficially owns 114,400 shares of Winmark common stock directly and 338 shares indirectly through a family office, along with multiple additional employee stock option awards with various exercise prices and expiration dates.

Winmark Corp (WINA) director reports option exercises and stock sale. A board member filed a Form 4 showing that on 11/19/2025 they exercised stock options for a total of 2,400 shares of common stock in three separate transactions of 800 shares each at exercise prices of $98.25, $125.5, and $122.5.

On 11/21/2025, the director sold 2,400 shares of Winmark common stock at a price of $420.87 per share. After these transactions, the director directly owns 2,500 shares of common stock and continues to hold multiple non-employee stock options covering additional shares of Winmark stock, with various exercise prices and expiration dates. The options noted as footnote (1) vest at a rate of 25% per year for four years.

Winmark (WINA) reported an insider transaction by its Chief Financial Officer, Anthony D. Ishaug. On 11/07/2025, the CFO exercised employee stock options (transaction code M) for a total of 3,000 shares, consisting of 2,490 shares at $98.25 and 510 shares at $195.82.

Following these transactions, the filing shows 66,483 shares of common stock held directly. The derivative table reflects the exercises from grants originally priced at $98.25 and $195.82, alongside remaining option positions with various exercise prices and expiration dates.

Winmark (WINA) reported insider activity by its Chief Operating Officer. On 10/22/2025, the COO exercised 2,500 stock options at an exercise price of $90.99 (transaction code M). On 10/24/2025, the COO sold 100 shares at $435.62 and 1,100 shares at $415.43 (transaction code S). Following these transactions, the officer beneficially owned 18,860 shares directly. The exercised options originated from a grant dated 12/14/2016 with an expiration of 12/14/2025 and vesting noted as 25% per year for four years.